Related Experiment Video
Updated: Dec 1, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Long-Term Follow-Up of Pericardium for the Ventricular Component in Atrioventricular Septal Defect Repair
Rinske J IJsselhof1, Saniyé D R Duchateau1, Rianne M Schouten2
1Division of Pediatrics, Department of Pediatric Cardiac Surgery, 8124University Medical Center Utrecht, the Netherlands.
Insights
Fresh untreated autologous pericardium and treated bovine pericardium are safe for ventricular septal defect closure in atrioventricular septal defect repair. Both materials showed no significant difference in left atrioventricular valve function or reoperation rates.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Biomaterials in Medicine
Background:
- Complete atrioventricular septal defect (AVSD) repair outcomes have improved, yet reoperations for left atrioventricular valve (LAVV) dysfunction remain frequent.
- Evaluating alternative materials for ventricular septal defect (VSD) closure is crucial to optimize AVSD repair outcomes.
Purpose of the Study:
- To assess the impact of fresh untreated autologous pericardium versus treated bovine pericardial patch material for VSD closure on subsequent LAVV function.
- To compare the long-term efficacy and safety of these two patch materials in AVSD repair.
Main Methods:
- A retrospective analysis of clinical and echocardiographic data from 77 patients with complete AVSD who underwent VSD closure between 1996 and 2003.
- Patients received either untreated autologous pericardium or treated bovine pericardial patch for VSD closure, with follow-up extending to September 2019.
Main Results:
- A total of 77 patients were analyzed, with 59 (77%) receiving autologous pericardium and 18 (23%) receiving bovine pericardium.
- Median follow-up was 17.5 years; two early deaths (3%) occurred. Reinterventions were necessary in eight patients, all within the autologous pericardium group.
- Log-rank tests revealed no significant differences in mortality (P=.892), LAVV reinterventions (P=.228), or LAVV regurgitation (P=.770) between the groups.
Conclusions:
- Both untreated autologous pericardium and xeno-pericardium (bovine pericardium) are safe options for VSD closure in AVSD repair.
- There was no discernible difference in the incidence of LAVV regurgitation or the requirement for reoperation between the two patch materials used.
Background:
Despite the improved outcome in complete atrioventricular septal defect (AVSD) repair, reoperations for left atrioventricular valve (LAVV) dysfunction are common. The aim of this study was to evaluate the effect of fresh untreated autologous pericardium for ventricular septal defect (VSD) closure on atrioventricular valve function and compare the results with the use of treated bovine pericardial patch material.
Methods:
Clinical and echocardiographic data were collected of patients with complete AVSD with their VSD closed with either untreated autologous pericardial or treated bovine pericardial patch material between January 1, 1996, and December 31, 2003. Evaluation closed in September 2019.
Results:
A total of 77 patients were analyzed (untreated autologous pericardial VSD patch: 59 [77%], treated bovine pericardial VSD patch: 18 [23%]). Median age at surgery was 3.6 (interquartile range [IQR]: 2.7-4.5) months, and median weight was 4.5 (IQR: 3.9-5.1) kg. Trisomy 21 was present in 70 (91%) patients. Median follow-up time was 17.5 (IQR: 12.6-19.8) years. Death <30 days occurred in two (3%) patients. Reinterventions occurred in eight patients (early [within 30 days] in two, early and late in one, and late in five), all in the autologous pericardium group. Log-rank tests showed no significant difference in mortality (P = .892), LAVV reinterventions (P = .228), or LAVV regurgitation (P = .770).
Conclusions:
In AVSD, the VSD can safely be closed with either untreated autologous pericardium or xeno-pericardium. We found no difference in LAVV regurgitation or the need for reoperation between the two patches.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care

